نتائج البحث - "Anti-PD-L1 monoclonal antibody"

العلاقة: Klinik für Strahlentherapie und Radioonkologie; Universitätsmedizin Göttingen; BMC Cancer. 2022 Sep 24;22(1):1011; https://resolver.sub.uni-goettingen.de/purl?gro-2/114285Test

الإتاحة: https://doi.org/10.1186/s12885-022-10074-9Test
https://resolver.sub.uni-goettingen.de/purl?gro-2/114285Test

View record in BASE

5

Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy

المؤلفون: Guanting Li, Wenli Zang, Kexin Shi, Xinyu Zhou, Shuwen Fu, Yinglei Zhai

المصدر: Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 12, Iss 1, Pp 92-106 (2022)

مصطلحات موضوعية: α-PD-L1, anti-PD-L1 monoclonal antibody, Carrier-free, IC50, half maximal inhibitory concentration, ITM, immunosuppressive tumor microenvironment, Drug resistance, Review, EPI, epirubicin, Medicine, Nanotechnology, ACT, adoptive cell transfer, ZHO, Z-Histidine-Obzl, DPDNAs, dual pure drug nano-assemblies, General Pharmacology, Toxicology and Pharmaceutics, PTT, photothermal therapy, media_common, DBNP, DOX-Ber nano-assemblies, PDNAs, pure drug nano-assemblies, FRET, Forster Resonance Energy Transfer, ATO, atovaquone, PD-1, PD receptor 1, TME, tumor microenvironment, RBC, red blood cell, Self-assembly, QSNAP, quantitative structure-nanoparticle assembly prediction, Anticancer drug, Pure drug, Cancer treatment, DBNP@CM, DBNP were cloaked with 4T1 cell membranes, Nanomedicine, PAI, photoacoustic imaging, PDT, photodynamic therapy, YSV, tripeptide tyroservatide, Drug delivery, CPT, camptothecin, DCs, dendritic cells, TNBC, triple negative breast, HMGB1, high-mobility group box 1, Drug, Carrier free, ATP, adenosine triphosphate, CTLs, cytotoxic T lymphocytes, media_common.quotation_subject, ICG, indocyanine green, PD-L1, PD receptor 1 ligand, Cancer therapy, ICD, immunogenic cell death, RM1-950, BV, Biliverdin, GEF, gefitinib, PPa, pheophorbide A, ABC, accelerated blood clearance, Ce6, chlorine e6, ROS, reactive oxygen species, NSCLC, non-small cell lung cancer, HCPT, hydroxycamptothecin, Combination therapy, NIR, near-infrared, TEM, transmission electron microscopy, EPR, enhanced permeability and retention, MTX, methotrexate, Nano-DDSs, nanoparticulate drug delivery systems, NPs, nanoparticles, Ber, berberine, Poly I:C, polyriboinosinic:polyribocytidylic acid, UA, ursolic acid, SPDNAs, single pure drug nano-assemblies, business.industry, MPDNAs, multiple pure drug nano-assemblies, ICB, immunologic checkpoint blockade, CI, combination index, TLR4, Toll-like receptor 4, TA, tannic acid, TTZ, trastuzumab, Top I & II, topoisomerase I & II, DOX, doxorubicin, PTX, paclitaxel, EGFR, epithelial growth factor receptor, MDS, molecular dynamics simulations, RNA, ribonucleic acid, dsRNA, double-stranded RNA, Therapeutics. Pharmacology, business, MRI, magnetic resonance imaging

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a15ad3659d8f272ed8ada8a0844bebTest
http://europepmc.org/articles/PMC8799886Test

6

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

المؤلفون: Lena Brückner, Mike Thomas, Marc A. Schneider, Inn Chung, Johannes Krisam, Farastuk Bozorgmehr, Stefan Rieken, Petros Christopoulos, Daniel Wilhelm Mueller

المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Durvalumab, medicine.medical_treatment, NSCLC, Severity of Illness Index, B7-H1 Antigen, Anti-PD-L1 monoclonal antibody, Study Protocol, 0302 clinical medicine, Non-small cell lung cancer, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Multicenter Studies as Topic, Prospective Studies, Geriatric risk profile, Stage (cooking), Immune Checkpoint Inhibitors, Lung, Antibodies, Monoclonal, Chemoradiotherapy, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Radiation Dose Hypofractionation, Immune checkpoint inhibition, Adult, medicine.medical_specialty, lcsh:RC254-282, 03 medical and health sciences, Clinical Trials, Phase II as Topic, Internal medicine, Biomarkers, Tumor, Genetics, medicine, Humans, Lung cancer, Neoplasm Staging, Pneumonitis, Hypofractionated radiation, Radioimmunotherapy, medicine.disease, Radiation Pneumonitis, Clinical trial, Radiation therapy, 030104 developmental biology, Concomitant, Quality of Life, Feasibility Studies, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2284b8db2e4b0f8f06430102c120bc37Test
http://link.springer.com/article/10.1186/s12885-020-07264-8Test

7

Application of Anti-PD-L1 Monoclonal Antibody Atezolizumab in Second Line Therapy of Common Urothelial Bladder Cancer

المؤلفون: Ye.V. Seredkin, S.P. Sidorov, Ye.A. Rybkina, S.S. Sidorova, D.M. Ponomarenko, Z.V. Dyakonenko, D.Yu. Yukalchuk, O.V. Baklanova

المصدر: Effective Pharmacotherapy. 15:30-34

مصطلحات موضوعية: Second-line therapy, Bladder cancer, business.industry, Atezolizumab, Cancer research, Medicine, business, medicine.disease, Anti-PD-L1 Monoclonal Antibody

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0344ec8b625e9396d466e063989345a9Test
https://doi.org/10.33978/2307-3586-2019-15-38-30-34Test

8

IBC‐Ab002, an anti‐PD‐L1 monoclonal antibody tailored for treating Alzheimer’s disease

المؤلفون: Alexander Kertser, Ofir Forsht, Eliezer Shochat, Eti Yoles, Shai Braiman, Kuti Baruch, Carol David, Omri Matalon

المصدر: Alzheimer's & Dementia. 16

مصطلحات موضوعية: Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Cancer research, Medicine, Neurology (clinical), Disease, Geriatrics and Gerontology, business, Anti-PD-L1 Monoclonal Antibody

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e41664583324466070f8f02527824388Test
https://doi.org/10.1002/alz.042978Test

9

Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

المصدر: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ee98dfedbd1e75a303941c4c4aec5bTest
http://link.springer.com/article/10.1186/s40425-018-0329-7Test

10

A defucosylated anti-PD-L1 monoclonal antibody 13-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma

المؤلفون: Hiroyuki Harada, Tomokazu Ohishi, Yukinari Kato, Junko Takei, Mika K. Kaneko, Manabu Kawada

المصدر: Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, Vol 24, Iss, Pp 100801-(2020)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f185d5e395ab3907932b923d49e0018Test
https://doi.org/10.1016/j.bbrep.2020.100801Test

تنقيح النتائج